Skip to the page

Data / Form D filings / Mirimus, Inc.

Mirimus, Inc.: Form D filings

Mirimus, Inc., a biotechnology company in Cold Spring Harbor, NY, filed 3 Form D notices with the SEC in 2011. The latest, on March 2, 2011, reports $2 million sold of a $2 million offering to 2 investors.

Find out what Mirimus, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1 BUNGTOWN ROAD, Cold Spring Harbor, NY, 11724
Phone
(646) 221-5960
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2010
Revenue range
Not Applicable
Exemptions claimed
Rule 506
SEC identifier (CIK)
1506012

The full lists. Form D filings in New York: 4,357 rows, $123.57, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Mar 2, 2011New notice$2,000,000$2,000,000$02Feb 17, 2011sec.gov
Feb 11, 2011Amendment$825$825$06Jan 28, 2011sec.gov
Jan 31, 2011New notice$825$775$506Jan 28, 2011sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Prem PremsrirutExecutive Officer, Director
Leo GuthartDirector
John MaroneyDirector
Steven WinickDirector

Other biotechnology companies in New York that filed recently

Every Form D from the week of Feb 28, 2011 · All recent filings in New York · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Mirimus, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.